Dr. Stacey Gugino, MD

NPI: 1346438157
Total Payments
$13,585
2024 Payments
$1,160
Companies
61
Transactions
727
Medicare Patients
3,449
Medicare Billing
$372,161

Payment Breakdown by Category

Food & Beverage$13,505 (99.4%)
Education$80.34 (0.6%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $13,505 724 99.4%
Education $80.34 3 0.6%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $1,852 133 $0 (2024)
Lilly USA, LLC $1,319 107 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $1,224 63 $0 (2024)
AstraZeneca Pharmaceuticals LP $1,066 44 $0 (2023)
Astellas Pharma US Inc $993.45 56 $0 (2024)
ABBVIE INC. $826.78 31 $0 (2024)
PFIZER INC. $605.29 34 $0 (2024)
Allergan, Inc. $527.85 10 $0 (2020)
GlaxoSmithKline, LLC. $375.49 25 $0 (2024)
Janssen Pharmaceuticals, Inc $361.23 21 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,160 59 Astellas Pharma US Inc ($239.59)
2023 $1,863 93 ABBVIE INC. ($264.12)
2022 $1,918 87 ABBVIE INC. ($356.90)
2021 $2,157 126 Novo Nordisk Inc ($388.59)
2020 $1,007 57 AstraZeneca Pharmaceuticals LP ($191.95)
2019 $2,204 118 Allergan Inc. ($364.13)
2018 $2,104 119 Boehringer Ingelheim Pharmaceuticals, Inc. ($337.25)
2017 $1,172 68 PFIZER INC. ($206.63)

All Payment Transactions

727 individual payment records from CMS Open Payments — Page 1 of 30

Date Company Product Nature Form Amount Type
12/23/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $20.11 General
Category: Gastroenterology
12/19/2024 Lilly USA, LLC JARDIANCE (Drug) Food and Beverage In-kind items and services $16.04 General
Category: Diabetes
12/15/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $19.68 General
Category: Diabetes
12/09/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $15.48 General
Category: Diabetes
11/21/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $18.75 General
Category: Diabetes
11/11/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $18.47 General
Category: Biological
11/06/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $21.50 General
Category: NEUROSCIENCE
11/04/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $14.17 General
Category: Obesity
10/24/2024 Edwards Lifesciences Corporation SAPIEN 3 Ultra RESILIA (Device) Food and Beverage In-kind items and services $28.56 General
Category: Transcatheter Heart Valves
10/10/2024 GlaxoSmithKline, LLC. SHINGRIX (Biological), AREXVY Food and Beverage In-kind items and services $19.37 General
Category: VACCINES
10/07/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $17.93 General
Category: Biological
09/30/2024 Amgen Inc. EVENITY (Biological), Prolia Food and Beverage In-kind items and services $22.01 General
Category: Bone Health
09/26/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $14.17 General
Category: PSYCHIATRY
09/23/2024 Ferring Pharmaceuticals Inc. REBYOTA (Biological) Food and Beverage In-kind items and services $18.98 General
Category: GASTROENTEROLOGY
09/19/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $19.37 General
Category: Oncology
09/10/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $12.63 General
Category: Obesity
09/09/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $17.82 General
Category: Biological
09/05/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.27 General
Category: NEUROSCIENCE
08/22/2024 ALK-Abello, Inc Odactra (Drug), Grastek, Ragwitek Food and Beverage In-kind items and services $25.43 General
Category: Allergy and Immunology
08/15/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $18.61 General
Category: Diabetes
08/11/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $18.90 General
Category: Diabetes
08/07/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $22.27 General
Category: Gastroenterology
08/05/2024 Astellas Pharma US Inc Veozah (Drug) Food and Beverage In-kind items and services $18.81 General
Category: Biological
07/25/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $21.25 General
Category: Oncology
07/22/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $14.58 General
Category: Inflammation

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 11 662 793 $138,047 $71,219
2022 15 752 1,144 $192,545 $93,656
2021 15 1,168 1,628 $279,435 $130,769
2020 17 867 1,076 $180,856 $76,516
Total Patients
3,449
Total Services
4,641
Medicare Billing
$372,161
Procedure Codes
70

All Medicare Procedures & Services

70 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99306 Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes Facility 2023 106 110 $27,940 $15,448 55.3%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 89 89 $35,600 $11,120 31.2%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2023 28 28 $8,960 $7,906 88.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 80 89 $15,130 $7,721 51.0%
99309 Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes Office 2023 54 80 $10,960 $6,299 57.5%
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes Office 2023 45 104 $10,816 $5,620 52.0%
99309 Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes Facility 2023 41 69 $9,453 $5,590 59.1%
99306 Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes Office 2023 24 27 $6,858 $3,692 53.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 40 40 $4,800 $2,299 47.9%
90662 Influenza vaccine split virus, preservative free Office 2023 28 28 $2,380 $2,014 84.6%
G0008 Administration of influenza virus vaccine Office 2023 34 34 $1,330 $958.25 72.0%
G0444 Annual depression screening, 5 to 15 minutes Office 2023 52 52 $1,300 $925.08 71.2%
G0009 Administration of pneumococcal vaccine Office 2023 28 28 $960.00 $824.52 85.9%
99308 Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes Facility 2023 13 15 $1,560 $802.76 51.5%
99306 Initial nursing facility visit per day, typically 45 minutes Facility 2022 129 137 $34,798 $17,348 49.9%
99309 Follow-up nursing facility visit per day, typically 25 minutes Facility 2022 70 235 $32,195 $15,762 49.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 97 97 $38,800 $12,433 32.0%
99309 Follow-up nursing facility visit per day, typically 25 minutes Office 2022 59 186 $25,482 $12,408 48.7%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 80 88 $14,588 $7,929 54.4%
99310 Follow-up nursing facility visit per day, typically 35 minutes Facility 2022 36 51 $8,925 $5,231 58.6%
90677 Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use Office 2022 18 18 $5,220 $5,013 96.0%
99306 Initial nursing facility visit per day, typically 45 minutes Office 2022 25 25 $6,350 $3,110 49.0%
99308 Follow-up nursing facility visit per day, typically 15 minutes Facility 2022 20 58 $6,032 $3,027 50.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 39 44 $4,878 $2,770 56.8%
99308 Follow-up nursing facility visit per day, typically 15 minutes Office 2022 24 48 $4,992 $2,225 44.6%

About Dr. Stacey Gugino, MD

Dr. Stacey Gugino, MD is a Family Medicine healthcare provider based in Williamsville, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346438157.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stacey Gugino, MD has received a total of $13,585 in payments from pharmaceutical and medical device companies, with $1,160 received in 2024. These payments were reported across 727 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($13,505).

As a Medicare-enrolled provider, Gugino has provided services to 3,449 Medicare beneficiaries, totaling 4,641 services with total Medicare billing of $372,161. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Williamsville, NY
  • Active Since 10/05/2007
  • Last Updated 02/02/2016
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1346438157

Products in Payments

  • JARDIANCE (Drug) $727.33
  • Ozempic (Drug) $719.41
  • TRULICITY (Drug) $656.53
  • FARXIGA (Drug) $624.81
  • UBRELVY (Drug) $427.28
  • XARELTO (Drug) $319.34
  • Saxenda (Drug) $311.06
  • Wegovy (Drug) $298.30
  • VRAYLAR (Drug) $269.07
  • CHANTIX (Drug) $267.74
  • Myrbetriq (Drug) $265.86
  • Veozah (Drug) $264.10
  • Vascepa (Drug) $260.14
  • ELIQUIS (Drug) $256.46
  • Victoza (Drug) $248.12
  • TRADJENTA (Drug) $241.22
  • QULIPTA (Drug) $232.68
  • ZENPEP (Drug) $222.84
  • ENTRESTO (Drug) $220.92
  • DALVANCE (Drug) $210.61

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Williamsville